STUDY OF COMPARATIVE PHARMACOKINETICS AND BIOEQUIVALENCE OF DRUGS AMLODIPINE + VALSARTAN AND EXFORGE®
- 作者: Khokhlov A.1,2, Miroshnikov A.3, Khokhlov A.3, Pozdnyakov N.3, Voronina E.1, Gerasimchuk S.3, Rybachkova Y.3, Manko K.4, Dubovik E.4
-
隶属关系:
- Road clinical hospital at Yaroslavl station JSC “Russian Railways”
- “Yaroslavl medical University”
- ClinPharmInvest
- AKRIKHIN
- 期: 卷 24, 编号 6 (2018)
- 页面: 299-305
- 栏目: Articles
- URL: https://journals.rcsi.science/0869-2106/article/view/38476
- DOI: https://doi.org/10.18821/0869-2106-2018-24-6-299-305
- ID: 38476
如何引用文章
全文:
详细
作者简介
A. Khokhlov
Road clinical hospital at Yaroslavl station JSC “Russian Railways”; “Yaroslavl medical University”150047, Yaroslavl, Russian Federation; 150000, Yaroslavl, Russian Federation
A. Miroshnikov
ClinPharmInvest150047, Yaroslavl, Russian Federation
A. Khokhlov
ClinPharmInvest150047, Yaroslavl, Russian Federation
N. Pozdnyakov
ClinPharmInvest150047, Yaroslavl, Russian Federation
E. Voronina
Road clinical hospital at Yaroslavl station JSC “Russian Railways”150047, Yaroslavl, Russian Federation
S. Gerasimchuk
ClinPharmInvest150047, Yaroslavl, Russian Federation
Yu. Rybachkova
ClinPharmInvest150047, Yaroslavl, Russian Federation
K. Manko
AKRIKHIN142450, Moscow region, Noginsk district, Staraya Kupavna, Russian Federation
E. Dubovik
AKRIKHIN142450, Moscow region, Noginsk district, Staraya Kupavna, Russian Federation
参考
- Шуникова М.И., Хохлов А.Л., Соснин А.Ю. Сравнительная оценка органопротективных свойств фозиноприла, амлодипина и метопролола у больных артериальной гипертонией. Consilium Medicum. 2008; 10(11): 30-5.
- Шальнова С.А., Кукушкин С., Маношкина Е., Тимофеева Т. Артериальная гипертензия и приверженность терапии. Врач. 2009: 12: 39-42.
- Конради А.О. Ключевые достижения в комбинированной антигипертензивной терапии последних лет. АГ. 2012; 6: 491-6.
- Хохлов А.Л., Рыска М., Кукес В.Г. Теоретические и практические основы проведения исследований воспроизведенных лекарственных препаратов: монография. ООО Фотолайф. 2017: 227.
- Poldermans D., Glazes R., Kargiannis S., Wernsing M., Kaczor J., Chiang Y.T., Yen J., Gamboa R., Fomina I. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Clin. Ther. 2007; 29(2): 279-89.
- Destro M., Luckow A., Samson M., Kandra A., Brunel P. Efficacy and safety of amlodipine/valsartan compared with amlodipine monotherapy in patients with stage 2 hypertension: a randomized, double-blind, multicenter study: the EX-EFFeCTS Study. J. Am. Soc. Hypertens. 2008; 2(4): 294-302.
- Khokhlov A.L., Ryska M., Kukes V.G. Theoretical and practical bases of research of reproduced medicinal products: monograph. LLC Fotolajf, 2017; 227. (in Russian)
- Smith T.R., Philipp T., Vaisse B., Bakris G.L., Wernsing M., Yen J., Glazer R. Amlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studies. J. Clin. Hypertens. 2007; 9(5): 355-64.
- Public Assessment Report Decentralised Procedure, (Valsartan), Procedure No: UK/H/3444/001-4/DC, UK licenceNo:PL 34771/0019-22, MacleodsPharma UK Limited, Medicines and Healthcare products Regulatory Agency, 2012.
- Public Assessment Report Scientific discussion, Valsartan “Mylan”, 40 mg, 80 mg and 160 mg capsules, hard, Valsartan, Procedure No: DK/H/1613/001-003/DC, 2010.
- Public Assessment Report Scientific discussion, Valsartan Cristers, 40 mg, 80 mg and 160 mg film-coated tablets (Valsartan), FR/H/410/01-03/DC, Applicant: Substipharm, 2011.
- Spinola A.C. et al. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions. Clin Ther. 2009. 31(9): 1992-2001.
- UK Public Assessment Report, Valsartan 40 mg film-coated tablets, Valsartan 80 mg film-coated tablets, Valsartan 160 mg film-coated tablets (valsartan), PL 20092/0045-7, Safeguarding public health, Medicines and Healthcare products Regulatory Agency, 2010.
- Carvalho M. et al. Amlodipine bioequivalence study: quantification by liquid chromatography coupled to tandem mass spectrometry. Biopharm Drug Dispos. 2001. 22(9): 383-90.
- Liu Y. et al. Pharmacokinetics and bioequivalence evaluation of two formulations of 10-mg amlodipine besylate: an open-label, single-dose,randomized, two-way crossover study in healthy Chinese male volunteers. Clin Ther. 2009; 31(4): 777-83.
- Setiawati E. et al. Bioequivalence Study of Two Amlodipine Tablet Formulations. Maj KedoktIndon. 2008; 58(2).
- Al-Tamimi J.J.I. Bioequivalence and Pharmacokinetics of Two Formulations of Amlodipine Tablets in Healthy Subjects. Iraqi J Pharm Sci. 2014; 23(1).